The global active pharmaceutical pngredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth.
A favorable government initiative for increasing focus toward generic drugs is a key factor for market growth. Decrease in generic drug prices, higher acceptance in low income and decrease in reimbursement for branded drugs are the recent trends in the market affirming growth of generic drugs.
Browse a Report@ http://www.orbisresearch.com/reports/index/active-pharmaceutical-ingredients-api-market-size-and-forecast-by-type-of-synthesis-biotech-synthetic-by-type-of-manufacturer-captive-merchant-by-type-generic-innovative-by-application-and-trend-analysis-2014-2025
Further Key Findings From the Study Suggest:
Synthetic APIs was the largest segment by revenue share in 2015 owing to high demand.
Biotech APIs are estimated to grow lucratively over the forecast period with high R&D initiatives being undertaken for their development
Captive manufacturers, being the conventional option of API manufacturing, held the majority of the share.
On the other hand, the merchant manufacturers segment is expected to be fastest-growing due to growing outsourcing activities
Request a sample copy of Report @ http://www.orbisresearch.com/contacts/request-sample/214494
Generic APIs will experience lucrative growth over the forecast period attributed to patent expirations of branded drugs
APIs are identified to have highest application in cardiovascular therapeutics. Increasing mortality caused by heart diseases and growing demand for fast-acting drugs are the major factors contributing to dominance
North America dominated in terms of revenue share in 2015 and Asia Pacific is expected to grow at a significant growth rate over the forecast period
Some of the major companies in the API market are AbbVie, Inc., Boehringer Ingelheim GmbH, Cipla, Inc., and Merck & Co., Inc
Buy a Report@ http://www.orbisresearch.com/contact/purchase/214494
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019